Drug Type Small molecule drug |
Synonyms- |
Target |
Action antagonists |
Mechanism S1PR4 antagonists(Sphingosine 1-phosphate receptor Edg-6 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Endocrinology and Metabolic Disease | Discovery | - | 22 Jun 2023 | |
| Infectious Diseases | Discovery | - | 22 Jun 2023 | |
| Ischemia | Discovery | - | 22 Jun 2023 | |
| Kidney Failure, Chronic | Discovery | - | 22 Jun 2023 | |
| liver function failure | Discovery | - | 22 Jun 2023 | |
| Nervous System Diseases | Discovery | - | 22 Jun 2023 | |
| Other Diseases | Discovery | - | 22 Jun 2023 |





